BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25414370)

  • 1. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
    Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
    Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment imaging can be used to select imaging guidance, ultrasound alone versus CT plus ultrasound, for percutaneous renal radiofrequency ablation.
    McGahan JP; Loh S; Fitzgerald E; Koppie T; Evans CP; Dall'Era M; Li CS
    AJR Am J Roentgenol; 2011 Nov; 197(5):1244-50. PubMed ID: 22021521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
    Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
    Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
    Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
    Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques?
    Veltri A; Garetto I; Pagano E; Tosetti I; Sacchetto P; Fava C
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):76-85. PubMed ID: 18709413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of ultrasound-guided radiofrequency ablation in the treatment of 36 renal cell carcinoma tumours compared with published results of using computed tomography guidance.
    Davis K; Kielar A; Jafari K
    Can Assoc Radiol J; 2012 Aug; 63(3 Suppl):S23-32. PubMed ID: 21145195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
    Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
    Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
    AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
    Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
    Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
    Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
    J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.